The therapeutic implications of the genomic analysis of malignant pleural mesothelioma

by Marjorie G. Zauderer
Published 2021-03-01

Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.

by Bob T Li, Emil Lou, Meier Hsu, Helena A Yu, Jarushka Naidoo, Marjorie G Zauderer, Camelia Sima, Melissa L Johnson, Mariza Daras, Lisa M DeAngelis, Martin Fleisher, Mark G Kris, Christopher G Azzoli
Published 2016-01-01

Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy

by Xiaoyu Li, Xiaoyu Li, Takashi Eguchi, Takashi Eguchi, Rania G. Aly, Rania G. Aly, Rania G. Aly, Navin K. Chintala, Kay See Tan, Marjorie G. Zauderer, Francine R. Dembitzer, Mary Beth Beasley, Berhane Ghebrehiwet, Prasad S. Adusumilli, Prasad S. Adusumilli, Ellinor I. B. Peerschke
Published 2019-10-01